Skip to main content
SpringerLink
Log in

Probiotic Research in Therapeutics

Volume 1: Applications in Cancers and Immunological Diseases

  • Book
  • © 2021

Overview

Editors:
  1. Indu Pal Kaur

    1. Panjab University, Chandigarh, India

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Parneet Kaur Deol

    1. G.H.G. Khalsa College of Pharmacy Gurusar Sadhar, Ludhiana, India

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Explains the relationship between gut dysbiosis and cancer

  • Explores the gut microbiota as a therapeutic target for management of cancer and immunological diseases

  • Presents latest information and key insights on application of probiotics in treatment of cancers and immunological diseases

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

  1. Front Matter

    Pages i-xiv
    Download chapter PDF

  2. Gut Microbiota and Cancer Correlates

    • Alok Malaviya, K. A. Paari, Shruti Malviya, Vamsi Krishna Kondapalli, Aditi Ghosh, Riya Ann Samuel
    Pages 1-27

  3. Potential Preventive and Therapeutic Accountability of Probiotics in Cancer: An Insight of Mechanism of Action

    • Pranav Kumar Prabhakar, Yachana Mishra, Vijay Mishra
    Pages 29-45

  4. Probiotics and Cancer: Boosting the Immune System

    • Prashant Upadhaya, Prachi Kharkar, Abhinandan Patil, Shivaji Pawar, John Disouza, Vandana B. Patravale
    Pages 47-67

  5. Probiotics as Next Generation Strategy for Cancer Therapy

    • Anuradha Mishra, Pragyandip P. Dash, Afreen Usmani, Satya Prakash Singh, Anup K. Sirbaiya
    Pages 69-94

  6. Metabiotics in Colorectal Cancer: Crosstalk Between Gut Microbiota and Host Pathology

    • Monica Gulati, Sachin Kumar Singh, Rajesh Kumar, Kamal Dua, Simanchal Panda, James Blaxland et al.
    Pages 95-112

  7. Possibility of Probiotic in Colorectal Cancer: A Specific Countenance to Research

    • Mohammad Yasir, Ruchi Khare, Pushpendra Singh, Sohni Singh, Rahul Shrivastava
    Pages 113-123

  8. Probiotics in Lung Cancer: An Emerging Field of Multifarious Potential and Opportunities

    • Mallesh Kurakula, Koteswara Rao G. S. N.
    Pages 125-158

  9. Probiotics for Prophylaxis and Management of Breast Cancer: Preclinical and Clinical Evidence

    • Sheyda Ranjbar, Seyed Afshin Seyednejad, Shahab Edalatian Zakeri, Hossein Rezaeizadeh, Roja Rahimi
    Pages 159-189

  10. Probiotics for Management of Gastrointestinal Cancers

    • Nilesh Rai, Anurag Kumar Singh, Priyanka Kumari Keshri, Suvakanta Barik, Swapnil C. Kamble, Santosh Kumar Singh et al.
    Pages 191-209

  11. Potential of Probiotics in the Management of Lung Cancer

    • G. Divyashri, T. P. Krishna Murthy, Manikanta Murahari
    Pages 211-230

  12. Bacteriocins of Probiotics as Potent Anticancer Agents

    • Pallvi Sharma, Santosh Kumar Tiwari
    Pages 231-250

  13. Probiotics in Autoimmune and Inflammatory Diseases

    • Vivek P. Chavda, Hitesh Prajapati, Punit Zadafiya, Moinuddin Soniwala
    Pages 251-271

  14. Role of Probiotics in Rheumatoid Arthritis

    • Rahul Shukla, Munindra Ruwali, N. Sharath Pawar, S. J. S. Flora
    Pages 273-294

  15. Genetically Engineered Probiotics

    • Saba Hag, Naresh Poondla
    Pages 295-328

  16. A Glance to the Patent World of Probiotics

    • Vivek P. Chavda, Arumugam Meyyappan, Disha Chavda, Moinuddin Soniwala
    Pages 329-367

  17. Correction to: Genetically Engineered Probiotics

    • Saba Haq, Naresh Poondla
    Pages C1-C1
Back to top

Keywords

About this book

The volume sheds new light on role of gut dysbiosis in cancer and immunological diseases and their clinical manifestations. Contributions in the volume discuss about the gut microbiota as a therapeutic target and the role of probiotics in its management. The volume explores application of probiotics in the treatment of various cancers viz. colorectal, gastric, lung, and breast cancer and immunological diseases. 
The volume comprises of chapters from expert contributors organized into various important themes which include, introduction, relationship between gut microbiota and disease condition, mechanisms involved, clinical and in vivo status, conclusion and future directions. This is a highly informative and carefully presented book, providing recent and innovative insight for scholars and researchers with an interest in probiotics and its applications in cancer and immunological diseases.

Editors and Affiliations

  • Panjab University, Chandigarh, India

    Indu Pal Kaur

  • G.H.G. Khalsa College of Pharmacy Gurusar Sadhar, Ludhiana, India

    Parneet Kaur Deol

About the editors

Dr Indu Pal Kaur is presently the Professor and Chairperson, at the University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, India. She has more than 25 years of teaching and research experience to her credit. She was Director Sophisticated Analytical Instrumentation Facility, Panjab University, from 2012 to 2015 and Dean - Faculty of Pharmaceutical Sciences, for session 2017-18. Her research forte is enhancing bioperformance of drugs, plant extracts/phytochemicals and small/large biomolecules viz. siRNA and probiotics using active-tailored delivery systems. She has been granted four Indian and one US patents and has filed 22 patents in the past 10 years. She has produced 23 PhDs and 55 postgraduates. She received funding to the tune of 72.3 million INR from Government agencies and has a couple of Industrial consultancies amounting to 15.3 million INR. Her research work was funded twice (2017 and 2020) by DST and Science and Techno^ 130 high impact International publications, and her group has received 31 Best Paper awards at National and International Conferences. She is a US-Fulbright fellow (2017-18) and was awarded Women Scientist Award -2018 by Organisation of Pharmaceutical Producers of India (OPPI). She has also been graced with BRIC Technology Exposition Award, consecutively for 2019 and 2020, Tynor Innovation Award- 2019 and Researcher of the Year award 2019, by Sunpure Research Incubation Center. Emphasis of her work lies on Industrial and clinical translation and is reflected through her three technology transfers to two Indian industries.


Dr Parneet Kaur Deol, is presently working as Assistant Professor at G.H.G. Khalsa College of Pharmacy Gurusar Sadhar Ludhiana, Punjab, India. She has more than 10 years of experience in probiotic research and has published her work in highly reputed peer reviewed international journals. She has 21 international publications to her credit with cumulative impact^50. She has co-edited a special issue for ‘Current Pharmaceutical Design’ with Prof. Indu Pal Kaur in the year 2019. Dr Deol has presented her work at various national and international platforms. She was awarded with the ‘Dr. Harpal Singh Buttar and Mrs. Harinder Kaur Buttar Award of Excellence in Pharmaceutical Sciences’ in the year 2016 and Mekaster Young Scientist Award in 2018 for her research work. Recently she fetched two research projects from Department of Science and Technology-Science and Engineering Research Board (DST-SERB), New Delhi worth 65 lakh.




Bibliographic Information

  • Book Title: Probiotic Research in Therapeutics

  • Book Subtitle: Volume 1: Applications in Cancers and Immunological Diseases

  • Editors: Indu Pal Kaur, Parneet Kaur Deol

  • DOI: https://doi.org/10.1007/978-981-15-8214-1

  • Publisher: Springer Singapore

  • eBook Packages: Chemistry and Materials Science, Chemistry and Material Science (R0)

  • Copyright Information: Springer Nature Singapore Pte Ltd. 2021

  • Hardcover ISBN: 978-981-15-8213-4Published: 14 November 2020

  • Softcover ISBN: 978-981-15-8216-5Published: 14 November 2021

  • eBook ISBN: 978-981-15-8214-1Published: 13 November 2020

  • Edition Number: 1

  • Number of Pages: XIV, 367

  • Number of Illustrations: 1 b/w illustrations, 38 illustrations in colour

  • Topics: Pharmaceutical Sciences/Technology, Immunology, Biomedical Engineering/Biotechnology

Publish with us

Policies and ethics

Back to top

Search

Navigation